Retina

CCSC treatment with Subliminal® Laser Therapy

05 December 2022

Tarragona, Spain

Dr Alejandro Filloy

Hospital Universitari Joan XXIII de Tarragona - Department of Ophthalmology

This is a treatment of a male patient with a history of CCSC in his right eye. SubLiminal® laser treatment with Easyret® was initiated in this patient. After 12 months, a significant improvement is observed.

Anamnesis :

49 year old patients with a history of CCSC in his right eye treated years ago with PDT. He presents with a recurrence of his condition with VA 20/50.

SubLiminal® Laser Therapy

<p>SubLiminal<strong>®</strong> Laser Therapy</p>

This patient receives Subliminal® treatment: 1090 spots, 160 microns, at 300mW (titrated at 850), encompassing most of the macular area, sparing the foveal area. 6 weeks after VA is 20/30 with complete SRF resolution and no visible reaction on autofluorescence.

Next follow up visit, 12 weeks after treatment: VA 20/25.

Final follow up visit, 12 months after treatment: VA 20/22, with a progressively more reconstituted outer retina.

SubLiminal® laser treatment was fully effective to resolve this CSCC recurrence in a context of unavailability of PDT.

Zoom on SubLiminal Laser Therapy

Subliminal laser is an alternative to the conventional continuous-wave laser for the treatment of retinal or macular diseases.

In contrast to the conventional laser, the therapeutic effect of the subthreshold laser is not accompanied by thermal retinal damage. This fact is of particular importance when a treatment near the fovea is required.

This laser method has been proven to be a safe and effective treatment option for macular pathologies such as central serous chorioretinopathy (CSC), diabetic macular edema (DME).

Want to know more about SubLiminal Laser Therapy ?

Visit our dedicated website: www.subliminal-laser-therapy.com

All our services

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.

I agree to my personal data being used by LUMIBIRD MEDICAL to send me marketing information about LUMIBIRD MEDIACL's new products, events or offers (mailings)

For more informations on how Lumibird Medical uses your data, please see our Terms and conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CCSC treatment with Subliminal® Laser Therapy

Anamnesis :

SubLiminal® Laser Therapy

Zoom on SubLiminal Laser Therapy

Continue reading ?